Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
561.00    -0.50 (-0.09%)
Bid:
560.50
Ask:
561.50
Spread: 1.00 (0.178%)
Market Cap: £2.48b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Directorate Change

3 Nov 2021 18:01

RNS Number : 2767R
Tate & Lyle PLC
03 November 2021
 

Tate & Lyle PLC - 3 November 2021

 

DIRECTORATE CHANGE

 

Tate & Lyle PLC (Tate & Lyle) announces that Vivid Sehgal, Chief Financial Officer, will leave the Company on 31 December 2021 for personal reasons. Vivid is stepping down from the Board today and will remain as Chief Financial Officer until the end of the year to support an orderly transition.

 

The process to appoint a successor to Mr Sehgal is underway and a further announcement will be made in due course.

 

Nick Hampton, Chief Executive said: "I am sorry to see Vivid leave and would like to thank him for his contribution to the Company. He has played an important role supporting Tate & Lyle's strategic transformation as well as maintaining strong financial discipline across the business. We wish him well for the future."

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is being released on behalf of Tate & Lyle by Claire-Marie O'Grady, Group Company Secretary.

 

For more information contact Tate & Lyle PLC:

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Media

Nick Hasell, FTI Consulting

Tel: Mobile: +44 (0) 7825 523 383

 

 

About Tate & Lyle:

Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

 

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

 

We have around 4,400 employees working in more than 60 locations across 30 countries. Tate & Lyle's purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

 

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2021, Tate & Lyle sales totalled £2.8 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on Twitter, Linkedin or Facebook.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFSSFADEFSESF
Date   Source Headline
22nd Aug 20245:45 pmRNSTransaction in Own Shares
22nd Aug 20244:00 pmRNSDirector/PDMR Shareholding
21st Aug 20246:00 pmRNSTransaction in Own Shares
20th Aug 20245:56 pmRNSTransaction in Own Shares
19th Aug 20245:44 pmRNSTransaction in Own Shares
16th Aug 20245:50 pmRNSTransaction in Own Shares
15th Aug 20245:57 pmRNSTransaction in Own Shares
14th Aug 20245:46 pmRNSTransaction in Own Shares
13th Aug 20245:54 pmRNSTransaction in Own Shares
13th Aug 20247:00 amRNSDirectorate Change
12th Aug 20245:43 pmRNSTransaction in Own Shares
9th Aug 20245:23 pmRNSTransaction in Own Shares
8th Aug 20245:50 pmRNSTransaction in Own Shares
8th Aug 20244:00 pmRNSDirector/PDMR Shareholding
7th Aug 20245:34 pmRNSTransaction in Own Shares
7th Aug 20244:05 pmRNSNotification of transactions by PDMRs
6th Aug 20245:29 pmRNSTransaction in Own Shares
5th Aug 20245:35 pmRNSTransaction in Own Shares
2nd Aug 20245:46 pmRNSTransaction in Own Shares
1st Aug 20245:28 pmRNSTransaction in Own Shares
1st Aug 20242:30 pmRNSTotal Voting Rights
31st Jul 20245:15 pmRNSTransaction in Own Shares
30th Jul 20245:23 pmRNSTransaction in Own Shares
29th Jul 20245:34 pmRNSTransaction in Own Shares
29th Jul 20242:00 pmRNSCompany Secretary Change
26th Jul 20245:33 pmRNSTransaction in Own Shares
25th Jul 20245:28 pmRNSTransaction in Own Shares
25th Jul 20242:00 pmRNSResult of AGM
25th Jul 20247:00 amRNSTrading Statement
24th Jul 20245:24 pmRNSTransaction in Own Shares
24th Jul 20245:15 pmRNSTotal Voting Rights
23rd Jul 20245:40 pmRNSTransaction in Own Shares
22nd Jul 20245:26 pmRNSTransaction in Own Shares
19th Jul 20245:33 pmRNSTransaction in Own Shares
18th Jul 20245:37 pmRNSTransaction in Own Shares
18th Jul 202410:00 amRNSDirector/PDMR Shareholding
17th Jul 20245:45 pmRNSTransaction in Own Shares
16th Jul 20245:25 pmRNSTransaction in Own Shares
15th Jul 20245:20 pmRNSTransaction in Own Shares
15th Jul 202411:00 amRNSHolding(s) in Company
12th Jul 20245:55 pmRNSTransaction in Own Shares
12th Jul 202411:00 amRNSBlock listing Interim Review
11th Jul 20245:30 pmRNSTransaction in Own Shares
10th Jul 20245:41 pmRNSTransaction in Own Shares
9th Jul 20245:24 pmRNSTransaction in Own Shares
8th Jul 20245:41 pmRNSTransaction in Own Shares
5th Jul 20245:49 pmRNSTransaction in Own Shares
5th Jul 20242:00 pmRNSDirector/PDMR Shareholding
4th Jul 20245:40 pmRNSTransaction in Own Shares
3rd Jul 20245:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.